The stock of ESSA Pharma Inc (TSE:EPI) is a huge mover today! About 14,600 shares traded hands or 25.59% up from the average. ESSA Pharma Inc (TSE:EPI) has declined 19.40% since April 29, 2016 and is downtrending. It has underperformed by 25.32% the S&P500.
The move comes after 9 months negative chart setup for the $86.39 million company. It was reported on Dec, 1 by Barchart.com. We have $2.90 PT which if reached, will make TSE:EPI worth $5.18M less.
More important recent ESSA Pharma Inc (TSE:EPI) news were published by: Prnewswire.com which released: “ESSA Pharma Inc. Receives FDA Approval to Commence Clinical Development” on September 23, 2015, also Prnewswire.com published article titled: “ESSA Pharma Inc. Receives FDA Response on IND Application”, Prnewswire.com published: “ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for …” on March 31, 2015. More interesting news about ESSA Pharma Inc (TSE:EPI) was released by: Prnewswire.com and their article: “ESSA Pharma Announces Closing of US$15 Million Private Placement” with publication date: January 14, 2016.
ESSA Pharma, Inc. is a Canada-based clinical-stage pharmaceutical company. The company has a market cap of $86.39 million. The Firm is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). It currently has negative earnings. The Company’s segment is the development of small molecule drugs for prostate cancer.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.